Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-18

Clinical Trial Update: Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Correction of Temple Hollowing [NA]

View source ↗

Summary

A clinical trial update regarding the safety and effectiveness of JUVÉDERM VOLUMA XC injectable gel for correcting temple hollowing has been terminated, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JUVÉDERM VOLUMA XC injectable gel (hyaluronic acid filler)

Snippet

Sponsor: Allergan | Conditions: Temple Hollowing | NA | Status: TERMINATED | Results posted: 2018-10-18